Biocon Q4 net dips 62% on MTM losses

It is clear that mark-to-market (MTM) has impacted our profit earnings for this year and quarter as well. I think the good news is going forward we have managed the stemming of MTM losses, said Kiran Mazumdar-Shaw, CMD, Biocon.

Related Videos